Retroviral gene transfer to human epidermal keratinocytes correlates with integrin expression and is significantly enhanced on fibronectin

Human Gene Therapy

Volumn 13, Issue 15, 2002, Pages 1821-1831

  Bajaj, Bharat ^a   Behshad, Shahram ^a   Andreadis, Stelios T ^a  

^a the State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HEXADIMETHRINE BROMIDE; INTEGRIN; INTEGRIN ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA MODIFICATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; PHENOTYPE; PRODUCTIVITY; PROTEIN BINDING; PROTEIN EXPRESSION; STEM CELL; TISSUE CULTURE; VIRAL GENE DELIVERY SYSTEM;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; CELL ADHESION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CULTURE MEDIA; FIBRONECTINS; GENETIC VECTORS; HEXADIMETHRINE; HUMANS; INTEGRIN ALPHA2; INTEGRIN ALPHA5; KERATINOCYTES; PLASTICS; RECOMBINANT PROTEINS; RETROVIRIDAE; TRANSDUCTION, GENETIC;

UNIDENTIFIED RETROVIRUS;

EID: 0036414893     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402760372927     Document Type: Article

References (79)

1. Abonour, R., Williams, D.A., Einhorn, L., Hall, K.M., Chen, J., Coffman, J., Traycoff, C.M., Bank, A., Kato, I., Ward, M., Williams, S.D., Hromas, R., Robertson, M.J., Smith, F.O., Woo, D., Mills, B., Srour, E.F., and Cornetta, K. (2000). Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat. Med. 6, 652-658.
2. Adams, J.C., and Watt, F.M. (1989). Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340, 307-309.
3. Adams, J.C., and Watt, F.M. (1990). Changes in keratinocyte adhesion during terminal differentiation: Reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface. Cell 63, 425-435.
4. Adams, J.C., and Watt, F.M. (1991). Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J. Cell. Biol. 115, 829-841.
5. Andreadis, S., Brott, D.A., Fuller, A.O., and Palsson, B.O. (1997). Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 71, 7541-7548.
6. Andreadis, S., Fuller, A.O., and Palsson, B.O. (1998). Cell cycle dependence of retroviral transduction: An issue of overlapping time scales. Biotechnol. Bioeng. 58, 272-281.
7. Andreadis, S., Lavery, T., Davis, H.E., Le Doux, J.M., Yarmush, M.L., and Morgan, J. (2000). Toward a more accurate quantitation of the activity of recombinant retroviruses: Alternatives to titer and multiplicity of infection. J. Virol. 74, 3431-3439.
8. Andreadis, S.T. (2002). Gene enhanced tissue engineering. In Biomedical Technology and Devices Handbook. J. Moore and G. Zouridakis, eds. (CRC Press, Boca Raton) in press.
9. Andreadis, S.T., Hamoen, K.E., Yarmush, M.L., and Morgarg J.R. (2001). Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 15, 898-906.
10. Asada, K., Uemori, T., Ueno, T., Hashino, K., Koyama, N., Kawamura, A., and Kato, I. (1998). Enhancement of retroviral gene transduction on a dish coated with a cocktail of two different polypeptides: One exhibiting binding activity toward target cells, and the other toward retroviral vectors. J. Biochem. (Tokyo) 123, 1041-1047.
11. Bajaj, B., Lei, P., and Andreadis, S.T. (2001). High efficiencies of gene transfer with immobilized recombinant retrovirus: Kinetics and optimization. Biotechnol. Prog. 17, 587-596.
12. Campisi, J., and Medrano, E.E. (1983). Cell cycle perturbations in normal and transformed fibroblasts caused by detachment from the substratum. J. Cell. Physiol. 114, 53-60.
13. Cao, T., Wang, X.J., and Roop, D.R. (2000). Regulated cutaneous gene delivery: The skin as a bioreactor. Hum. Gene Ther. 11, 2297-2300.
14. Carter, W. G., Ryan, M.C., and Gahr, P.J. (1991). Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes. Cell 65, 599-610.
15. Carter, W.G., Wayner, E.A., Bouchard, T.S., and Kaur, P. (1990). The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J. Cell. Biol. 110, 1387-1404.
16. Cavazzana-Calvo, M., Hacein-Bey, S., De Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Deist, F.L., and Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
17. Challita, P.M., and Kohn, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 2567-2571.
18. Choate, K.A., and Khavari, P.A. (1997). Sustainability of keratinocyte gene transfer and cell survival in vivo. Hum. Gene Ther. 8, 895-901.
19. Choate, K.A., Kinsella, T.M., Williams, M.L., Nolan, G.P., and Khavari, P.A. (1996a). Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum. Gene Ther. 7, 2247-2253.
20. Choate, K.A., Medalie, D.A., Morgan, J.R., and Khavari, P.A. (1996b). Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Med. 2, 1263-1267.
21. Chuck, A.C., Clarke, M.F., and Palsson, B.O. (1996). Retroviral infection is limited by brownian motion. Hum. Gene Ther. 7, 1527-1534.
22. Conneally, E., Eaves, C.J., and Humphries, R.K. (1998). Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 91, 3487-3493.
23. Dao, M.A., Hashino, K., Kato, I., and Nolta, J.A. (1998). Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 92, 4612-4621.
24. Dardalhon, V., Noraz, N., Pollok, K., Rebouissou, C., Boyer, M., Bakker, A.Q., Spits, H., and Taylor, N. (1999). Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. Hum. Gene Ther. 10, 5-14.
25. Davison, E., Diaz, R.M., Hart, I.R., Santis, G., and Marshall, J.F. (1997). Integrin alpha5betal-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J. Virol. 71, 6204-6207.
26. De Luca, M., and Pellegrini, G. (1997). The importance of epidermal stem cells in keratinocyte-mediated gene therapy [editorial]. Gene Ther. 4, 381-383.
27. Dellambra, E., Vailly, J., Pellegrini, G., Bondanza, S., Golisano, O., Macchia, C., Zambruno, G., Meneguzzi, G., and De Luca, M. (1998). Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum. Gene Ther. 9, 1359-1370.
28. Donahue, R.E., Sorrentino, B.P., Hawley, R.G., An, D.S., Chen, I.S., and Wersto, R.P. (2001). Fibronectin fragment CH296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells. Mol. Ther. 3, 359-367.
29. Eming, S.A., Lee, J., Snow, R.G., Tompkins, R.G., Yarmush, M.L., and Morgan, J.R. (1995). Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice: Implications for the use of genetically modified keratinocytes to modulate dermal regeneration. J. Invest. Dermatol. 105, 756-763.
30. Eming, S.A., Snow, R.G., Yarmush, M.L., and Morgan, J.R. (1996). Targeted expression of insulin-like growth factor to human keratinocytes: Modification of the autocrine control of keratinocyte proliferation. J. Invest. Dermatol. 107, 113-120.
31. Fenjves, E.S., Schwartz, P.M., Blaese, R.M., and Taichman, L.B. (1997). Keratinocyte gene therapy for adenosine deaminase deficiency: A model approach for inherited metabolic disorders. Hum. Gene Ther. 8, 911-917.
32. Fenjves, E.S., Smith, J., Zaradic, S., and Taichman, L.B. (1994). Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy. Hum. Gene Ther. 5, 1241-1248.
33. Fenjves, E.S., Yao, S.N., Kurachi, K., and Taichman, L.B. (1996). Loss of expression of a retrovirus-transduced gene in human keratinocytes. J. Invest. Dermatol. 106, 576-578.
34. Freiberg, R.A., Choate, K.A., Deng, H., Alperin, E.S., Shapiro, L.J., and Khavari, P.A. (1997). A model of corrective gene transfer in X-linked ichthyosis. Hum. Mol. Genet. 6, 927-933.
35. Gerrard, A.J., Hudson, D.L., Brownlee, G.G., and Watt, F.M. (1993). Towards gene therapy for haemophilia B using primary human keratinocytes. Nat. Genet. 3, 180-183.
36. Ghazizadeh, S., and Taichman, L.B. (2000). Virus-mediated gene transfer for cutaneous gene therapy. Hum. Gene Ther. 11, 2247-2251.
37. Giancotti, F.G., and Ruoslahti, E. (1999). Integrin signaling. Science 285, 1028-1032.
38. Hanenberg, H., Hashino, K., Konishi, H., Hock, R.A., Kato, I., and Williams, D.A. (1997). Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum. Gene Ther. 8, 2193-2206.
39. Hanenberg, H., Xiao, X.L., Dilloo, D., Hashino, K., Kato, I., and Williams, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2, 876-882.
40. Hoeben, R.C., Migchielsen, A.A., Van Der Jagt, R.C., Van Ormondt, H., and Van Der Eb, A.J. (1991). Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65, 904-912.
41. Jones, P.H., Harper, S., and Watt, F.M. (1995). Stem cell patterning and fate in human epidermis. Cell 80, 83-93.
42. Jones, P.H., and Watt, F.M. (1993). Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73, 713-724.
43. Kiem, H.P., Andrews, R.G., Morris, J., Peterson, L., Heyward, S., Allen, J.M., Rasko, J.E., Potter, J., and Miller, A.D. (1998). Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92, 1878-1886.
44. Kim, J.P., Zhang, K., Chen, J.D., Wynn, K.C., Kramer, R.H., and Woodley, D.T. (1992a). Mechanism of human keratinocyte migration on fibronectin: Unique roles of RGD site and integrins. J. Cell. Physiol. 151, 443-450.
45. Kim, J.P., Zhang, K., Kramer, R.H., Schall, T.J., and Woodley, D.T. (1992b). Integrin receptors and RGD sequences in human keratinocyte migration: Unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J. Invest. Dermatol. 98, 764-770.
46. Kolodka, T.M., Garlick, J.A., and Taichman, L.B. (1998). Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 95, 4356-4361.
47. Kotani, H., Newton, P.B.I., Zhang, S., Chiang, Y.L., Otto, E., Weaver, L., Blaese, R.M., Anderson, W.F., and Mcgarrity, G.J. (1994). Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
48. Kozak, S.L., Siess, D.C., Kavanaugh, M.P., Miller, A.D., and Kabat, D. (1995). The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J. Virol. 69, 3433-3440.
49. Lauffenburger, D.A., and Linderman, J.J. (1993). Receptors. (Oxford University Press, New York).
50. Ledoux, J.M., Davis, H.E., Yarmush, M.L., and Morgan, J.R. (1999). Kinetics of retrovirus production and decay. Biotech. Bioeng. 63, 654-662.
51. Lei, P., Bajaj, B., and Andreadis, S.T. (2002). Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin. J. Virol. 76, 8722-8728.
52. Li, E., Brown, S.L., Stupack, D.G., Puente, X.S., Cheresh, D.A., and Nemerow, G.R. (2001). Integrin alphavbeta1 is an adenovirus coreceptor. J. Virol. 75, 5405-5409.
53. Macneill, E.C., Hanenberg, H., Pollok, K.E., Van Der Loo, J.C., Bierhuizen, M.F., Wagemaker, G., and Williams, D.A. (1999). Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296. J. Virol. 73, 3960-3967.
54. Martin, K.H., Slack, J.K., Boerner, S.A., Martin, C.C., and Parsons, J.T. (2002). Integrin connections map: To infinity and beyond. Science 296, 1652-1653.
55. Meng, X., Sawamura, D., Tamai, K., Hanada, K., Ishida, H., and Hashimoto, I. (1998). Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J. Clin. Invest. 101, 1462-1467.
56. Miller, A.D., and Buttimore, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
57. Miller, A.D., and Rosman, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-982, 984-986, 989-990.
58. Miller, D.G., Adam, M.A., and Miller, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
59. Morgan, J.R., Barrandon, Y., Green, H., and Mulligan, R.C. (1987). Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237, 1476-1479.
60. Moritz, T., Dutt, P., Xiao, X., Carstanjen, D., Vik, T., Hanenberg, H., and Williams, D.A. (1996). Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88, 855-862.
61. Page, S.M., and Brownlee, G.G. (1997). An ex vivo keratinocyte model for gene therapy of hemophilia B. J. Invest. Dermatol. 109, 139-145.
62. Pollok, K.E., Hanenberg, H., Noblitt, T.W., Schroeder, W.L., Kato, I., Emanuel, D., and Williams, D.A. (1998). High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J. Virol. 72, 4882-4892.
63. Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
64. Sackman, J.E., Wymore, A.M., Reddick, T.T., Freeman, M.B., Stevens, S.L., and Goldman, M.H. (1997). Retroviral mediated gene transduction alters integrin expression on vascular endothelial cells. J. Surg. Res. 69, 45-50.
65. Salmeen, I., Rimai, L., Luftig, R.B., Liebes, L., Retzer, E., Rich, M., and Mccormick, J.J. (1976). Hydrodynamic diameters of murine mammary, rous sarcoma and feline leukemia RNA tumor viruses: Studies by laser beat frequency light-scattering spectroscopy and electron microscopy. J. Virol. 17, 584-596.
66. Sarret, Y., Stamm, C., Jullien, D., and Schmitt, D. (1992). Keratinocyte migration is partially supported by the cell-binding domain of fibronectin and is RGDS-dependent. J. Invest. Dermatol. 99, 656-659.
67. Selkirk, S.M., Greenberg, S.J., Plunkett, R.J., Barone, T.A., Lis, A., and Spence, P.O. (2002). Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes. Gene Ther. 9, 432-443.
68. Staiano-Coico, L., and Higgins, P.J. (1992). Cell shape changes during transition of basal keratinocytes to mature enucleate-cornified envelopes: Modulation of terminal differentiation by fibronectin. Exp. Cell Res. 201, 126-136.
69. Sullivan, D.M., Jensen, T.G., Taichman, L.B., and Csaky, K.G. (1997). Ornithine-delta-aminotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: Toward metabolic sink therapy for gyrate atrophy. Gene Ther. 4, 1036-1044.
70. Summerford, C., Bartlett, J.S., and Samulski, R.J. (1999). AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82.
71. Takashima, A., and Grinnell, F. (1985). Fibronectin-mediated keratinocyte migration and initiation of fibronectin receptor function in vitro. J. Invest. Dermatol. 85, 304-308.
72. Toyoshima, K., and Vogt, P.K. (1969). Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 38, 414-426.
73. Valera, A., Perales, J.C., Hatzoglou, M., and Bosch, F. (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5, 449-456.
74. Watt, F.M. (2000). Epidermal stem cells as targets for gene transfer. Hum. Gene Ther. 11, 2261-2266.
75. Wickham, T.J., Filardo, E.J., Cheresh, D.A., and Nemerow, G.R. (1994). Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127, 257-264.
76. Wickham, T.J., Mathias, P., Cheresh, D.A., and Nemerow, G.R. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
77. Yajima, T., Kanda, T., Yoshiike, K., and Kitamura, Y. (1998). Retroviral vector targeting human cells via c-Kit-stem cell factor interaction. Hum. Gene Ther. 9, 779-787.
78. Zhang, Z., Vuori, K., Reed, J.C., and Ruoslahti, E. (1995). The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. U.S.A. 92, 6161-6165.
79. Zhu, A. J., Haase, I., and Watt, F.M. (1999). Signaling via betal integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. Proc. Natl. Acad. Sci. U.S.A. 96, 6728-6733.